Psychiatric medications are among the most prescribed and least discussed interventions in medicine. Approximately one in six American adults reports taking a psychiatric drug, most often an antidepressant. Despite the prevalence of these medications, conversations about what they do, how well they work, what their limitations are, and what alternatives exist are less common in clinical practice than the prescription rate would suggest. The public narrative around psychiatric medication has long been dominated by two equally incomplete framings: that these medications correct chemical imbalances and restore normal brain function, or that they are overused tools of social control with more risk than benefit. Neither framing serves patients well.
Rethinking the Serotonin Hypothesis
The chemical imbalance theory, that depression is caused by insufficient serotonin and antidepressants work by correcting this deficiency, was a compelling narrative that simplified the marketing of selective serotonin reuptake inhibitors in the 1990s and early 2000s. A comprehensive 2022 review in Molecular Psychiatry examined the evidence across multiple lines of research and found no consistent evidence that depression is associated with low serotonin or serotonin deficiency. This is not a fringe finding. It is the conclusion of a systematic examination of the evidence by a team of researchers at University College London.
This does not mean antidepressants do not work. Substantial evidence from meta-analyses of randomized controlled trials shows that antidepressants are significantly more effective than placebo for moderate to severe depression, with effect sizes that are clinically meaningful for the patients most severely affected. What it means is that the mechanistic explanation patients have been given, a story about correcting a chemical imbalance, is not supported by the evidence. Antidepressants work through mechanisms that are incompletely understood, and honest informed consent requires acknowledging this rather than perpetuating a simplified narrative that overstates our knowledge.
What Patients Deserve to Know
Informed consent for psychiatric medication should include several components that are often omitted or minimized. The realistic range of likely benefit for the specific condition and severity. The fact that the first medication tried may not be the most effective, and that finding the right medication often involves a process of adjustment. The side effect profile, including effects that are common and those that are rare but serious. The potential difficulty of discontinuation, particularly for antidepressants and benzodiazepines, which can produce withdrawal-like symptoms that are often mistaken for relapse and that patients may not be warned about before starting treatment.
Patients also deserve to know about the evidence for non-pharmacological alternatives. For depression of mild to moderate severity, psychotherapy, particularly cognitive behavioral therapy, shows efficacy comparable to antidepressant medication in most meta-analyses. For anxiety disorders, CBT shows superior long-term outcomes compared to medication for most patients, with lower relapse rates after treatment ends. Exercise has randomized trial evidence for depression comparable to antidepressants in some studies. These alternatives are not inferior options for patients who refuse medication. They are evidence-based first-line treatments for many patients.
Medication as Part of a Treatment Plan
For many patients with significant psychiatric conditions, medication is an important part of an effective treatment plan. Severe depression, bipolar disorder, schizophrenia, and panic disorder are among the conditions where the evidence for medication is strongest and where medication is often necessary for adequate stabilization. The question is not whether medication has a role but what role it plays in relation to psychotherapy, lifestyle factors, social support, and the other evidence-based components of comprehensive care. Prescribing medication without attending to these other dimensions, or without monitoring response and adjusting when patients are not improving, is not adequate psychiatric care regardless of whether the medication itself is appropriate.
